AGXT and hereditary sensory and autonomic neuropathy type 1: In the hereditary sensory neuropathy type 1 rodent model, SPT deficiency causes mTOR activation by suppressing the phosphatase PP2A, a negative regulator of mTORC1 (64, 65).